Protocol for the Study and Treatment of Patients With Intraocular Retinoblastoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antineoplastics; Carboplatin; Doxorubicin; Etoposide; Granulocyte colony stimulating factor inhibitors; Topotecan; Vincristine
- Indications Retinoblastoma
- Focus Pharmacogenomic; Therapeutic Use
- 05 Feb 2021 Biomarkers information updated
- 19 Jun 2013 Planned end date changed from 1 Dec 2015 to 1 Nov 2016 as reported by ClinicalTrials.gov.
- 28 Jul 2011 Planned end date changed from 1 Jan 2011 to 1 Dec 2015 as reported by ClinicalTrials.gov.